Published in Cancer Epidemiol Biomarkers Prev on November 01, 2002
Loss of T cell responses following long-term cryopreservation. J Immunol Methods (2007) 1.23
Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Carcinogenesis (2010) 0.86
Epstein-Barr virus-transformation of B-cell lines in ovarian cancer patients: feasibility of genomic storage for unlimited use. J Gynecol Oncol (2009) 0.78
Analytical validation of telomerase activity for cancer early detection: TRAP/PCR-CE and hTERT mRNA quantification assay for high-throughput screening of tumor cells. J Mol Diagn (2004) 0.77
Peripheral blood immunologic phenotype of population-based breast cancer cases and matched controls. Eur J Clin Invest (2011) 0.75
Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women. Osteoporos Int (2016) 0.75
Methods for etiologic and early marker investigations in the PLCO trial. Mutat Res (2005) 3.33
Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst (2008) 3.04
The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell (2009) 2.22
Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis (2009) 2.17
Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk. Hum Mol Genet (2008) 1.96
A systematic review of vitamin D receptor gene polymorphisms and prostate cancer risk. J Urol (2006) 1.86
Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev (2008) 1.80
High-throughput single nucleotide polymorphism genotyping using nanofluidic Dynamic Arrays. BMC Genomics (2009) 1.76
RNASEL Arg462Gln polymorphism and prostate cancer in PLCO. Prostate (2007) 1.74
Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev (2013) 1.58
Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study. Cancer Epidemiol Biomarkers Prev (2007) 1.58
Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res (2006) 1.52
Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol Biomarkers Prev (2006) 1.46
Variant in sex hormone-binding globulin gene and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.27
Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control (2010) 1.21
A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma. Blood (2009) 1.20
HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites. Breast Cancer Res Treat (2003) 1.19
IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Int J Cancer (2007) 1.19
Endogenous sex hormones and the risk of prostate cancer: a prospective study. Int J Cancer (2008) 1.17
Genetic variation in base excision repair genes and the prevalence of advanced colorectal adenoma. Cancer Res (2007) 1.15
Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Causes Control (2008) 1.13
Association of energy intake and energy balance with postmenopausal breast cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev (2006) 1.11
Genetic variants of DNA repair genes and prostate cancer: a population-based study. Cancer Epidemiol Biomarkers Prev (2005) 1.06
A prospective evaluation of C-reactive protein levels and colorectal adenoma development. Cancer Epidemiol Biomarkers Prev (2011) 1.06
Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer. Cancer Res (2010) 1.06
GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev (2005) 1.05
IL-15 administered by continuous infusion to rhesus macaques induces massive expansion of CD8+ T effector memory population in peripheral blood. Blood (2011) 1.03
DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients. Laryngoscope (2005) 1.00
CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma. Carcinogenesis (2005) 0.99
Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States). Cancer Causes Control (2005) 0.98
Epidemiologic considerations to assess altered DNA methylation from environmental exposures in cancer. Ann N Y Acad Sci (2003) 0.98
Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. Cancer Res (2009) 0.97
A prospective study of serum metabolites and colorectal cancer risk. Cancer (2014) 0.96
Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Carcinogenesis (2013) 0.96
Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial. Am J Gastroenterol (2010) 0.96
Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. J Clin Oncol (2013) 0.95
TNF polymorphisms and prostate cancer risk. Prostate (2008) 0.95
Sugarcane farming, occupational solvent exposures, and the risk of oral cancer in Puerto Rico. J Occup Environ Med (2003) 0.93
Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Int J Cancer (2014) 0.92
Association of Coffee Consumption With Overall and Cause-Specific Mortality in a Large US Prospective Cohort Study. Am J Epidemiol (2015) 0.91
Nitric oxide synthase gene polymorphisms and prostate cancer risk. Carcinogenesis (2009) 0.91
Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies. Carcinogenesis (2007) 0.90
Iron homeostasis and distal colorectal adenoma risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Prev Res (Phila) (2011) 0.90
Characterization of effect of repeated freeze and thaw cycles on stability of genomic DNA using pulsed field gel electrophoresis. Biopreserv Biobank (2012) 0.90
Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer. Prostate (2007) 0.89
Microsatellite polymorphisms in the epidermal growth factor receptor (EGFR) gene and the transforming growth factor-alpha (TGFA) gene and risk of oral cancer in Puerto Rico. Pharmacogenet Genomics (2005) 0.88
Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma. Cancer Epidemiol Biomarkers Prev (2007) 0.88
DNA repair gene polymorphisms and tobacco smoking in the risk for colorectal adenomas. Carcinogenesis (2011) 0.87
The impact of smoking on the severity of acute ischemic stroke. J Neurol Sci (2011) 0.87
Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma. Carcinogenesis (2007) 0.86
Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Carcinogenesis (2010) 0.86
Association of obesity with cardiovascular disease mortality in the PLCO trial. Prev Med (2013) 0.85
Gouty arthritis in acute cerebrovascular disease. Cerebrovasc Dis (2009) 0.84
Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer. Int J Cancer (2013) 0.84
Lack of association of transforming growth factor-beta1 polymorphisms and haplotypes with prostate cancer risk in the prostate, lung, colorectal, and ovarian trial. Cancer Epidemiol Biomarkers Prev (2007) 0.83
The association between inflammation-related genes and serum androgen levels in men: the prostate, lung, colorectal, and ovarian study. Prostate (2011) 0.82
Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: utility of fluorescence in situ hybridization (FISH) in a case-control study. Leuk Res (2009) 0.82
Gastrointestinal hemorrhage after acute ischemic stroke and its risk factors in Asians. Eur Neurol (2009) 0.82
Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk. Eur J Cancer (2010) 0.82
Click-chemistry-conjugated oligo-angiomax in the two-dimensional DNA lattice and its interaction with thrombin. Biomacromolecules (2009) 0.81
Variants of DNA repair genes and the risk of biliary tract cancers and stones: a population-based study in China. Cancer Epidemiol Biomarkers Prev (2008) 0.81
A case-control study of tobacco use and other non-occupational risk factors for lymphoma subtypes defined by t(14; 18) translocations and bcl-2 expression. Cancer Causes Control (2010) 0.80
Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin. Cancer Epidemiol Biomarkers Prev (2010) 0.79
The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource. Rev Recent Clin Trials (2015) 0.79
Xenobiotic metabolizing genes, meat-related exposures, and risk of advanced colorectal adenoma. World Rev Nutr Diet (2010) 0.78
First-ever ischemic stroke in very old Asians: clinical features, stroke subtypes, risk factors and outcome. Eur Neurol (2007) 0.78
Genetic variants in frizzled-related protein (FRZB) and the risk of colorectal neoplasia. Cancer Causes Control (2008) 0.78
PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies. Rev Recent Clin Trials (2015) 0.77
Clinical characteristics of adult tetanus in a Taiwan medical center. J Formos Med Assoc (2011) 0.76
Less favorable neurological recovery after acute stroke in patients with hypercholesterolemia. Clin Neurol Neurosurg (2013) 0.76
Xenobiotic metabolizing genes, meat-related exposures, and risk of advanced colorectal adenoma. J Nutrigenet Nutrigenomics (2011) 0.75
Laboratory detective work identifies a mishandling problem in sample aliquoting. Biopreserv Biobank (2014) 0.75
AFM and multiple transmission-reflection infrared spectroscopy (MTR-IR) studies on formation of air-stable supported lipid bilayers. Int J Mol Sci (2009) 0.75
Peripheral blood immunologic phenotype of population-based breast cancer cases and matched controls. Eur J Clin Invest (2011) 0.75
Innate immunity gene polymorphisms and the risk of colorectal neoplasia. Carcinogenesis (2013) 0.75
Lymphocyte subsets in hemophilic patients with hepatitis C virus infection with or without human immunodeficiency virus co-infection: a nested cross-sectional study. BMC Blood Disord (2005) 0.75
Very early hemorrhagic transformation of a subcortical infarction. Acta Neurol Taiwan (2008) 0.75
Aspirin use and mortality in two contemporary U.S. cohorts. Epidemiology (2017) 0.75